Literature DB >> 9351454

Angiotensin II-induced leukocyte adhesion on human coronary endothelial cells is mediated by E-selectin.

M Gräfe1, W Auch-Schwelk, A Zakrzewicz, V Regitz-Zagrosek, P Bartsch, K Graf, M Loebe, P Gaehtgens, E Fleck.   

Abstract

Clinical data suggest a link between the activation of the renin-angiotensin system and cardiovascular ischemic events. Leukocyte accumulation in the vessel wall is a hallmark of early atherosclerosis and plaque progression. E-Selectin, vascular cell adhesion molecule-1 (VCAM-1), and intercellular adhesion molecule-1 (ICAM-1) are adhesion molecules participating in mediating interactions between leukocytes and endothelial cells and have been found to be expressed in athero-sclerotic plaques. We investigated whether angiotensin II, the effector of the renin-angiotensin system, influences the endothelial expression of E-selectin, VCAM-1, and ICAM-1. In coronary endothelial cells derived from explanted human hearts, angiotensin II (10(-11) to 10(-5) mol/L) induced a concentration-dependent increase in E-selectin expression. The effect was measured by cell ELISA and duplex reverse-transcription polymerase chain reaction (RT-PCR) and reached its maximum at 10(-7) mol/L. Angiotensin II induced only a small increase in E-selectin expression in cardiac microvascular endothelial cells. VCAM-1 and ICAM-1 were not affected by angiotensin II stimulation. In addition, the effect of angiotensin II-induced E-selectin expression on leukocyte adhesion was quantified under flow conditions. Angiotensin II (10(-7) mol/L) increased leukocyte adhesion significantly to 67% of the maximal effect by tumor necrosis factor-alpha at a wall shear stress of 2 dyne/cm2. This adhesion was found to be E-selectin dependent, as demonstrated by blocking antibodies. The AT1-receptor antagonist DUP 753 significantly reduced E-selectin-dependent adhesion, whereas the AT2-receptor antagonist PD 123177 had no inhibitory effect. In addition, only AT1-receptor, but not AT2-receptor, mRNA could be detected by RT-PCR in coronary endothelial cells. Therefore, it is suggested that AT1 receptors mediate the effects of angiotensin II on E-selectin expression and leukocyte adhesion on coronary endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9351454     DOI: 10.1161/01.res.81.5.804

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  18 in total

Review 1.  Monocytes as immune targets in arterial hypertension.

Authors:  Philip Wenzel
Journal:  Br J Pharmacol       Date:  2018-07-14       Impact factor: 8.739

2.  Effect of asiatic acid on the Ang II-AT1R-NADPH oxidase-NF-κB pathway in renovascular hypertensive rats.

Authors:  Putcharawipa Maneesai; Sarawoot Bunbupha; Upa Kukongviriyapan; Laddawan Senggunprai; Veerapol Kukongviriyapan; Parichat Prachaney; Poungrat Pakdeechote
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-07-21       Impact factor: 3.000

3.  Immunosuppressive treatment protects against angiotensin II-induced renal damage.

Authors:  Dominik N Muller; Erdenechimeg Shagdarsuren; Joon-Keun Park; Ralf Dechend; Eero Mervaala; Franziska Hampich; Anette Fiebeler; Xinsheng Ju; Piet Finckenberg; Jürgen Theuer; Christiane Viedt; Joerg Kreuzer; Harald Heidecke; Hermann Haller; Martin Zenke; Friedrich C Luft
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

Review 4.  Anti-inflammatory strategies in hypertension: focus on COX-1 and COX-2.

Authors:  Matthias Hermann; Frank Enseleit; Frank T Ruschitzka
Journal:  Curr Hypertens Rep       Date:  2005-02       Impact factor: 5.369

5.  Losartan attenuates bleomycin induced lung fibrosis by increasing prostaglandin E2 synthesis.

Authors:  M Molina-Molina; A Serrano-Mollar; O Bulbena; L Fernandez-Zabalegui; D Closa; A Marin-Arguedas; A Torrego; J Mullol; C Picado; A Xaubet
Journal:  Thorax       Date:  2006-04-06       Impact factor: 9.139

6.  Effect of two phenanthrene alkaloids on angiotensin II-induced leukocyte-endothelial cell interactions in vivo.

Authors:  Rossana Estellés; Javier López-Martín; Lara Milian; José-Enrique O'Connor; Magdalena Martínez-Losa; Miguel Cerdá-Nicolás; Edet M Anam; María Dolores Ivorra; Andrew C Issekutz; Julio Cortijo; Esteban J Morcillo; Maria Amparo Blázquez; Maria-Jesús Sanz
Journal:  Br J Pharmacol       Date:  2003-10-14       Impact factor: 8.739

7.  Renin inhibition reduces hypercholesterolemia-induced atherosclerosis in mice.

Authors:  Hong Lu; Debra L Rateri; David L Feldman; Richard J Charnigo; Akiyoshi Fukamizu; Junji Ishida; Elizabeth G Oesterling; Lisa A Cassis; Alan Daugherty
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

8.  Angiotensin AT1 receptor antagonists exert anti-inflammatory effects in spontaneously hypertensive rats.

Authors:  Q Dai; M Xu; M Yao; B Sun
Journal:  Br J Pharmacol       Date:  2007-10-08       Impact factor: 8.739

9.  Augmentation of the renin-angiotensin system by hypercholesterolemia promotes vascular diseases.

Authors:  Alan Daugherty; Hong Lu; Debra L Rateri; Lisa A Cassis
Journal:  Future Lipidol       Date:  2008-12

Review 10.  Cardiovascular effects of losartan and its relevant clinical application.

Authors:  Feichao Xu; Caiping Mao; Yali Hu; Can Rui; Zhice Xu; Lubo Zhang
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.